| scholarly article | Q13442814 |
| P2093 | author name string | Ji Chen | |
| Xi Chen | |||
| Ming Liu | |||
| Zhen Liu | |||
| Yi Zheng | |||
| Feng Xu | |||
| Yu Deng | |||
| Feng Bi | |||
| Qiu Li | |||
| Meng Qiu | |||
| Qiulin Tang | |||
| Siyuan Zhang | |||
| Jitao Zhou | |||
| Nan Lang | |||
| Yajie Zhu | |||
| P2860 | cites work | Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel-Lindau suppression and HIF1alpha activation | Q28290117 |
| RHO-GTPases and cancer | Q29616099 | ||
| MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Q29616316 | ||
| Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation | Q29618303 | ||
| Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways | Q34596683 | ||
| Gene targeting of Cdc42 and Cdc42GAP affirms the critical involvement of Cdc42 in filopodia induction, directed migration, and proliferation in primary mouse embryonic fibroblasts | Q35128385 | ||
| Rho GTPases as key transducers of proliferative signals in g1 cell cycle regulation | Q35681628 | ||
| MicroRNA and cancer: Current status and prospective | Q36681096 | ||
| Motility-related proteins as markers for head and neck squamous cell cancer | Q36739644 | ||
| MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. | Q38353056 | ||
| Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. | Q39528226 | ||
| Cell attachment to the extracellular matrix induces proteasomal degradation of p21(CIP1) via Cdc42/Rac1 signaling | Q39674970 | ||
| Epigenetic regulation of microRNA expression in colorectal cancer | Q39838959 | ||
| Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer | Q39996295 | ||
| Growth and motility inhibition of breast cancer cells by epidermal growth factor receptor degradation is correlated with inactivation of Cdc42. | Q40296481 | ||
| Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. | Q52583131 | ||
| Rho GTPases are over-expressed in human tumors. | Q53423587 | ||
| miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 | ||
| miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
| The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 | Q24608778 | ||
| miRBase: tools for microRNA genomics | Q24649872 | ||
| Combinatorial microRNA target predictions | Q27860510 | ||
| Rho GTPases: biochemistry and biology | Q27860645 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Rho GTPases in cell biology | Q27860969 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 | ||
| miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells | Q28278471 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 1269-1279 | |
| P577 | publication date | 2011-03-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells | |
| P478 | volume | 128 |
| Q38605223 | A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer. |
| Q28533254 | A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q48624606 | Association of microRNA137 gene polymorphisms with age at onset and positive symptoms of schizophrenia in a Han Chinese population |
| Q21245480 | Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells |
| Q35834449 | Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy |
| Q33688815 | Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer |
| Q26998741 | DNA methylation and microRNA dysregulation in cancer |
| Q39097075 | Differential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42. |
| Q21135494 | Differential expression of microRNAs in tumors from chronically inflamed or genetic (APC(Min/+)) models of colon cancer |
| Q37973293 | Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer |
| Q38402820 | Endometriosis risk alleles at 1p36.12 act through inverse regulation of CDC42 and LINC00339. |
| Q37718295 | Epigenetic silencing of miR-137 contributes to early colorectal carcinogenesis by impaired Aurora-A inhibition. |
| Q39550203 | Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer |
| Q92358733 | Extensive transcriptional responses are co-ordinated by microRNAs as revealed by Exon-Intron Split Analysis (EISA) |
| Q58593876 | FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation |
| Q39386679 | Functional investigation of a schizophrenia GWAS signal at the CDC42 gene |
| Q40467191 | Heme oxygenase-1 protects spinal cord neurons from hydrogen peroxide-induced apoptosis via suppression of Cdc42/MLK3/MKK7/JNK3 signaling. |
| Q38717174 | High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients |
| Q34032893 | Homotypic cell cannibalism, a cell-death process regulated by the nuclear protein 1, opposes to metastasis in pancreatic cancer |
| Q53653473 | Identification of high-risk Dukes B colorectal cancer by microRNA expression profiling: a preliminary study. |
| Q37732544 | Identification of senescence-inducing microRNAs in normal human keratinocytes |
| Q30353926 | Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo. |
| Q41974346 | Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients. |
| Q38796401 | MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12. |
| Q41018062 | MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells |
| Q89460802 | MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma |
| Q34314172 | MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells |
| Q38952716 | MiR-137: an important player in neural development and neoplastic transformation. |
| Q34497810 | MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators |
| Q35363689 | MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation |
| Q36517482 | MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application |
| Q34182764 | MicroRNA signatures differentiate melanoma subtypes |
| Q42123071 | MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. |
| Q48168117 | MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer. |
| Q38749382 | MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion |
| Q39600575 | MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. |
| Q39358880 | MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer |
| Q42267770 | MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer |
| Q49624843 | MicroRNA-761 promotes the sensitivity of colorectal cancer cells to 5-Fluorouracil through targeting FOXM1. |
| Q38962311 | MicroRNA-Mediated Reprogramming of Somatic Cells into Neural Stem Cells or Neurons. |
| Q26775610 | MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer |
| Q38550157 | MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer |
| Q38815583 | MicroRNAs regulate KDM5 histone demethylases in breast cancer cells |
| Q42172356 | Myocyte Enhancer Factor 2A Regulates Hydrogen Peroxide-Induced Senescence of Vascular Smooth Muscle Cells Via microRNA-143. |
| Q26778962 | Non-muscle myosin II in disease: mechanisms and therapeutic opportunities |
| Q26864697 | Noncoding RNAs in DNA repair and genome integrity |
| Q37077405 | Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma |
| Q28385469 | Ouabain suppresses the migratory behavior of lung cancer cells |
| Q39158791 | Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1. |
| Q39415400 | Overexpression of miR-506 suppresses proliferation and promotes apoptosis of osteosarcoma cells by targeting astrocyte elevated gene-1 |
| Q30538395 | Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer |
| Q39037078 | PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro |
| Q61452256 | Polarity as a physiological modulator of cell function |
| Q30454963 | Potential Impact of miR-137 and Its Targets in Schizophrenia |
| Q52622319 | Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates. |
| Q39099530 | Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. |
| Q38885469 | Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer |
| Q43141227 | Restoration of BRG1 inhibits proliferation and metastasis of lung cancer by regulating tumor suppressor miR-148b |
| Q37454682 | Review of MicroRNA Proposed Target Genes in Oral Cancer. Part II. |
| Q26999290 | Rho GTPase regulation by miRNAs and covalent modifications |
| Q47211731 | Roles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells |
| Q37997954 | Schizophrenia genetics: putting all the pieces together |
| Q34994130 | Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation |
| Q90224514 | The Differential DNA Hypermethylation Patterns of microRNA-137 and microRNA-342 Locus in Early Colorectal Lesions and Tumours |
| Q30380229 | The Roles of Two miRNAs in Regulating the Immune Response of Sea Cucumber |
| Q38123756 | The role of microRNAs in tumors |
| Q38979078 | Transcriptional targets of the schizophrenia risk gene MIR137. |
| Q34449094 | Tumor-microenvironment interactions studied by zonal transcriptional profiling of squamous cell lung carcinoma |
| Q39100702 | Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. |
| Q42272607 | Upregulation of miR-137 protects anesthesia-induced hippocampal neurodegeneration. |
| Q54391163 | miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. |
| Q38971368 | miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway |
| Q39062167 | miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin |
| Q47196122 | miR-137 inhibits melanoma cell proliferation through downregulation of GLO1. |
| Q42719038 | miR-137 inhibits renal cell carcinoma growth in vitro and in vivo |
| Q39244918 | miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes |
| Q39239384 | miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. |
| Q39609457 | miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. |
| Q37581142 | miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells |
| Q46037039 | miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. |
| Q55016678 | miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4. |
| Q38838174 | miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1. |
| Q33597730 | miR-185 enhances the inhibition of proliferation and migration induced by ionizing radiation in melanoma |
| Q42114395 | miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells |
| Q39483435 | miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells |
| Q40109846 | miR-29a promotes hepatitis B virus replication and expression by targeting SMARCE1 in hepatoma carcinoma |
| Q64120537 | miR-552-5p facilitates osteosarcoma cell proliferation and metastasis by targeting WIF1 |
| Q38809695 | microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR. |
| Q34501834 | microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma. |
| Q61626102 | microRNAs in the Malignant Transformation Process |
| Q26865206 | microRNAs: key triggers of neuronal cell fate |
| Q37480778 | srGAP1 mediates the migration inhibition effect of Slit2-Robo1 in colorectal cancer. |
Search more.